0,826  0,014  Apoptosis agonist
0,782  0,018  Antiinflammatory
0,674  0,006  AR expression inhibitor
0,668  0,022  Antineoplastic (lung cancer)
0,651  0,016  CYP2C9 substrate
0,656  0,026  Antineoplastic (breast cancer)
0,645  0,020  Teratogen
0,622  0,006  UGT1A4 substrate
0,627  0,020  Embryotoxic
0,612  0,010  NOS2 expression inhibitor
0,602  0,013  Immunosuppressant
0,615  0,027  CYP3A4 substrate
0,599  0,024  Antileukemic
0,590  0,015  CYP2C19 substrate
0,582  0,016  Sensitization
0,561  0,006  Antidiabetic symptomatic
0,542  0,004  Contraceptive
0,549  0,013  Nitric oxide antagonist
0,526  0,009  Antineoplastic (endocrine cancer)
0,551  0,034  TNF expression inhibitor
0,527  0,021  Carcinogenic
0,504  0,005  Antiacne
0,499  0,005  Abortion inducer
0,512  0,019  Cytostatic
0,489  0,005  UGT2B7 substrate
0,493  0,019  Proliferative diseases treatment
0,481  0,013  UDP-glucuronosyltransferase substrate
0,492  0,030  Respiratory analeptic
0,486  0,024  Antineoplastic (cervical cancer)
0,479  0,029  Antihypercholesterolemic
0,493  0,045  Transcription factor NF kappa B inhibitor
0,463  0,017  UGT2B4 substrate
0,449  0,005  Lipocortins synthesis antagonist
0,475  0,037  Cholesterol antagonist
0,450  0,013  UGT1A1 substrate
0,476  0,040  Antipruritic, allergic
0,461  0,029  Cytotoxic
0,457  0,026  NOS3 expression inhibitor
0,434  0,004  UGT2B9 substrate
0,435  0,010  Prostatic (benign) hyperplasia treatment
0,455  0,034  Antineoplastic (ovarian cancer)
0,426  0,007  Pneumotoxic
0,439  0,030  Antineoplastic (pancreatic cancer)
0,410  0,006  Antiviral (Influenza A)
0,410  0,010  Prostate disorders treatment
0,467  0,074  Caspase 9 stimulant
0,394  0,004  Estrogen receptor beta antagonist
0,393  0,011  Antipruritic, non-allergic
0,389  0,011  Topoisomerase II inhibitor
0,379  0,005  Estrogen antagonist
0,378  0,006  Antineoplastic antibiotic
0,384  0,012  Antiviral (Influenza)
0,417  0,048  Prostate cancer treatment
0,376  0,014  Melanin inhibitor
0,397  0,035  Antioxidant
0,425  0,066  Antibacterial
0,387  0,037  Chemoprotective
0,376  0,026  Sodium/bile acid cotransporter inhibitor
0,361  0,013  Hair growth stimulant
0,388  0,041  Analeptic
0,382  0,040  Antineoplastic (glioma)
0,351  0,010  Interleukin 6 antagonist
0,420  0,080  Antidiabetic
0,420  0,080  Cyclophilin D inhibitor
0,353  0,015  Carcinogenic, group 3
0,384  0,047  ICAM1 expression inhibitor
0,360  0,030  Vascular (periferal) disease treatment
0,379  0,050  Hepatic disorders treatment
0,364  0,049  Antineoplastic (melanoma)
0,366  0,052  CYP2D6 substrate
0,359  0,047  CTGF expression inhibitor
0,348  0,037  Mutagenic
0,370  0,060  Antineoplastic (colorectal cancer)
0,363  0,058  Antineoplastic (colon cancer)
0,339  0,036  Chemopreventive
0,335  0,042  Cardiovascular analeptic
0,309  0,018  Lipid peroxidase inhibitor
0,293  0,005  Estrogen agonist
0,320  0,038  Antiparasitic
0,307  0,028  Hepatoprotectant
0,315  0,039  DNA synthesis inhibitor
0,292  0,018  UGT2B15 substrate
0,334  0,061  Calcium channel activator
0,277  0,010  Expectorant
0,307  0,041  5 Hydroxytryptamine uptake stimulant
0,272  0,008  Androgen antagonist
0,266  0,004  Estrogen receptor beta agonist
0,274  0,013  Antifungal enhancer
0,282  0,023  Interferon gamma antagonist
0,298  0,045  UGT1A6 substrate
0,282  0,036  Antihelmintic
0,252  0,006  Mucolytic
0,284  0,039  Antiviral (HIV)
0,266  0,027  UGT1A3 substrate
0,245  0,007  Arachidonic acid antagonist
0,311  0,075  Antifungal
0,257  0,027  Skin irritative effect
0,238  0,017  UGT2B10 substrate
0,228  0,009  Contraceptive male
0,264  0,046  Antihypotensive
0,284  0,067  UGT1A9 substrate
0,230  0,013  Alcohol dehydrogenase substrate
0,222  0,007  Estrogen receptor alpha antagonist
0,220  0,013  Topoisomerase II alpha inhibitor
0,261  0,059  Antineoplastic (glioblastoma multiforme)
0,226  0,033  Anesthetic
0,196  0,005  UGT2B11 substrate
0,195  0,005  Anabolic
0,194  0,004  Aldosterone antagonist
0,283  0,095  Bone diseases treatment
0,192  0,005  Estrogen receptor alpha agonist
0,207  0,020  Carcinogenic, group 2B
0,233  0,047  P-glycoprotein inhibitor
0,193  0,007  Vanilloid agonist
0,255  0,070  Antiprotozoal (Leishmania)
0,262  0,078  Aldehyde oxidase inhibitor
0,201  0,018  SULT1A1 substrate
0,237  0,054  VCAM1 expression inhibitor
0,295  0,113  GST A substrate
0,196  0,015  Antineoplastic alkaloid
0,223  0,046  Antimutagenic
0,171  0,006  Androgen agonist
0,224  0,062  Anesthetic general
0,184  0,024  Microtubule formation inhibitor
0,269  0,109  FMO1 substrate
0,189  0,030  Antiviral (Hepatitis B)
0,163  0,006  5-Alpha-reductase inhibitor
0,176  0,020  Contraceptive female
0,236  0,081  Antineoplastic (sarcoma)
0,197  0,045  Toxic, respiratory center
0,230  0,079  Angiogenesis stimulant
0,214  0,064  Neurotrophic factor enhancer
0,233  0,082  Antineoplastic (liver cancer)
0,181  0,032  Cholesterol synthesis inhibitor
0,175  0,026  Growth stimulant
0,175  0,027  Endometrios treatment
0,160  0,013  SULT1E1 substrate
0,191  0,045  Protein kinase stimulant
0,197  0,052  Succinate dehydrogenase inhibitor
0,153  0,012  CDC25A inhibitor
0,192  0,054  Eye irritation, high
0,253  0,115  Interleukin 2 agonist
0,149  0,012  Postmenopausal disorders treatment
0,180  0,044  Aldose reductase substrate
0,211  0,076  Antihypertriglyceridemic
0,136  0,004  Glucocorticoid antagonist
0,138  0,006  Progesterone antagonist
0,158  0,027  Ca2+-transporting ATPase inhibitor
0,167  0,038  Adenylate cyclase stimulant
0,184  0,061  Antirickettsial
0,162  0,043  Antieczematic
0,170  0,052  Genotoxic
0,130  0,013  Glycine receptor antagonist
0,232  0,115  CYP1A2 substrate
0,205  0,089  Antineoplastic (lymphoma)
0,169  0,057  NOS3 expression enhancer
0,130  0,018  Keratolytic
0,132  0,021  Inducible nitric-oxide synthase inhibitor
0,143  0,034  Antiviral (Influenza B)
0,235  0,126  Caspase 3 stimulant
0,174  0,066  Antihelmintic (Nematodes)
0,233  0,125  GST M1-1 substrate
0,122  0,015  Na+ K+ transporting ATPase inhibitor
0,175  0,071  Sigma receptor agonist
0,137  0,035  Sulfotransferase substrate
0,235  0,135  Antineoplastic (osteosarcoma)
0,105  0,005  Postcoital contraceptive
0,138  0,040  Choleretic
0,222  0,127  Hypoxia-inducible factor 1 alpha inhibitor
0,149  0,054  Farnesoid X receptor antagonist
0,101  0,006  RNA-directed RNA polymerase stimulant
0,134  0,040  GABA C receptor antagonist
0,141  0,048  Vanilloid 1 agonist
0,120  0,027  Antibiotic
0,209  0,119  Antiosteoporotic
0,149  0,060  Neurotrophic factor
0,199  0,110  Antineoplastic (renal cancer)
0,106  0,018  Ca(v)3.1 blocker
0,120  0,032  Actinic keratosis treatment
0,153  0,065  Movement disorders treatment
0,224  0,140  Antineoplastic (brain cancer)
0,111  0,030  Transcription factor NF kappa B stimulant
0,088  0,009  Lipocortins synthesis agonist
0,101  0,023  Cushing's syndrome treatment
0,139  0,063  Skin whitener
0,082  0,006  Pregnane X receptor antagonist
0,191  0,117  Tumour necrosis factor alpha release inhibitor
0,087  0,017  SULT2A1 substrate
0,125  0,059  Monophenol monooxygenase inhibitor
0,117  0,051  UGT2B1 substrate
0,127  0,064  Coagulant
0,232  0,172  GABA C receptor rho-3 antagonist
0,110  0,050  Antineoplastic, alkylator
0,061  0,004  Progesterone agonist
0,114  0,059  Topoisomerase I inhibitor
0,094  0,041  Opioid kappa receptor antagonist
0,114  0,061  DNA intercalator
0,082  0,030  Anticholelithogenic
0,057  0,007  5-Alpha-reductase 1 inhibitor
0,066  0,017  Potassium channel Kv1.3 blocker
0,132  0,083  Antineoplastic (carcinoma)
0,066  0,018  Anesthetic inhalation
0,180  0,133  RNA-directed DNA polymerase inhibitor
0,110  0,063  Electron transport complex I inhibitor
0,051  0,007  5-Alpha-reductase 2 inhibitor
0,206  0,163  Angiogenesis inhibitor
0,196  0,154  Antineoplastic (multiple myeloma)
0,073  0,032  Aromatase inhibitor
0,083  0,043  Narcotic antagonist
0,142  0,104  Antipruritic
0,165  0,127  Antialcoholic
0,058  0,021  Mineralocorticoid receptor antagonist
0,049  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,111  0,074  Menstruation disorders treatment
0,108  0,071  Protein-tyrosine phosphatase 1B inhibitor
0,056  0,020  Microtubule stabilization
0,046  0,010  Tubulin agonist
0,069  0,033  Antimycoplasmal
0,165  0,129  Antineoplastic enhancer
0,048  0,012  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,066  0,031  Heme oxygenase stimulant
0,102  0,067  Toll-Like receptor 4 antagonist
0,156  0,124  CYP2B6 inhibitor
0,109  0,078  DNA polymerase I inhibitor
0,107  0,076  Antitussive
0,048  0,019  Hypogonadism treatment
0,186  0,158  Antihypoxic
0,084  0,056  Antispirochetal
0,097  0,071  Glutathione S-transferase substrate
0,178  0,155  Cardioprotectant
0,085  0,062  Ornithine decarboxylase inhibitor
0,029  0,007  Retinoic acid gamma receptor agonist
0,031  0,009  Retinoic acid receptor agonist
0,126  0,106  Protein-tyrosine phosphatase inhibitor
0,028  0,008  Corticosteroid-like
0,137  0,118  Sedative
0,083  0,065  Opioid antagonist
0,054  0,037  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,019  0,004  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,084  0,069  Triose-phosphate isomerase inhibitor
0,142  0,128  Antiviral (Hepatitis)
0,120  0,105  Diuretic
0,026  0,012  Estrone sulfatase inhibitor
0,109  0,095  Antihyperlipoproteinemic
0,027  0,014  Vanilloid 2 agonist
0,022  0,010  Retinoic acid beta receptor agonist
0,036  0,024  Retinoid X receptor agonist
0,051  0,039  Protein 50S ribosomal subunit inhibitor
0,078  0,066  GABA A receptor agonist
0,016  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,019  0,008  Telomerase stimulant
0,064  0,053  Premenstrual syndrome treatment
0,095  0,084  GABA receptor agonist
0,021  0,010  Progesterone receptor B antagonist
0,022  0,012  Retinoic acid alpha receptor antagonist
0,063  0,054  Hypercalcemia treatment
0,118  0,110  SULT1A3 substrate
0,027  0,018  Retinoid X gamma receptor antagonist
0,023  0,014  Vitamin D receptor antagonist
0,040  0,032  Kainate receptor agonist
0,020  0,012  Retinoic acid receptor antagonist
0,068  0,060  Glycine receptor agonist
0,035  0,028  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,098  0,092  TRPA1 agonist
0,015  0,009  Glucocorticoid agonist
0,104  0,098  Tubulin antagonist
0,019  0,013  Antibiotic Anthracycline-like
0,069  0,065  SULT1A2 substrate
0,138  0,134  Phospholipase C inhibitor
0,173  0,169  Antiepileptic
0,039  0,037  DNA gyrase subunit A inhibitor
0,005  0,004  Transcortin receptor antagonist
0,041  0,040  Adenylate cyclase 1 inhibitor
0,011  0,010  Retinoic acid receptor gamma antagonist
0,020  0,020  Retinoid X gamma receptor agonist
0,010  0,010  Retinoic acid beta receptor antagonist

